Zoth Lota S. 4

What Happened

• Zoth Lota S., a director of INOVIO PHARMACEUTICALS, INC. (INO), received equity awards on May 20, 2026: 41,800 derivative awards (stock options) and 34,200 restricted stock units (RSUs). The grants are recorded at $0.00 (awards), so no cash was paid by the insider. Both awards vest 100% on May 20, 2027 and were made under the company’s 2023 Omnibus Incentive Plan pursuant to the issuer’s non-employee director compensation policy.

Key Details

• Transaction date: May 20, 2026; Transaction code: A (award/grant).
• Awarded: 41,800 stock options (derivative) and 34,200 RSUs; reported acquisition price $0.00 (award).
• Vesting: Options vest 100% on May 20, 2027 (F2); RSUs vest 100% on May 20, 2027 and each RSU converts to one share upon vesting (F3).
• Plan/Policy: Grants made under the 2023 Omnibus Incentive Plan per non-employee director compensation policy (F1).
• Shares owned after transaction: Not specified in the filing.
• Filing timeliness: Report filed May 21, 2026 for a May 20, 2026 grant — appears to have been filed promptly (not marked late).

Context

• These awards are compensation for a non-employee director rather than an open-market purchase or sale. RSUs represent a contingent right to receive shares at vesting; the options are a derivative award that vests next year. The filing does not disclose exercise price or immediate market value, and awards do not reflect an immediate purchase or sale of shares.